首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2056781篇
  免费   208257篇
  国内免费   2037篇
  2267075篇
  2018年   20697篇
  2017年   19522篇
  2016年   30623篇
  2015年   44710篇
  2014年   53081篇
  2013年   79390篇
  2012年   61315篇
  2011年   55249篇
  2010年   51922篇
  2009年   50622篇
  2008年   50094篇
  2007年   50215篇
  2006年   50898篇
  2005年   51368篇
  2004年   50551篇
  2003年   47558篇
  2002年   45367篇
  2001年   71910篇
  2000年   70670篇
  1999年   60174篇
  1998年   30426篇
  1997年   30324篇
  1996年   29009篇
  1995年   27251篇
  1994年   26757篇
  1993年   26393篇
  1992年   51237篇
  1991年   49286篇
  1990年   47991篇
  1989年   47820篇
  1988年   44360篇
  1987年   42382篇
  1986年   39915篇
  1985年   41190篇
  1984年   36665篇
  1983年   31849篇
  1982年   27961篇
  1981年   26172篇
  1980年   24472篇
  1979年   33777篇
  1978年   28582篇
  1977年   26643篇
  1976年   25162篇
  1975年   26433篇
  1974年   28308篇
  1973年   28320篇
  1972年   25109篇
  1971年   23084篇
  1970年   20155篇
  1969年   19659篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
We have identified mouse and human FKBP60, a new member of the FKBP gene family. FKBP60 shares strongest homology with FKBP65 and SMAP. FKBP60 contains a hydrophobic signal peptide at the N-terminus, 4 peptidyl-prolyl cis/trans isomerase (PPIase) domains and an endoplasmic reticulum retention motif (HDEL) at the C-terminus. Immunodetection of HA-tagged FKBP60 in NIH-3T3 cells suggests that FKBP60 is segregated to the endoplasmic reticulum. Northern blot analysis shows that FKBP60 is predominantly expressed in heart, skeletal muscle, lung, liver and kidney. With N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as a substrate, recombinant GST-FKBP60 is shown to accelerate effectively the isomerization of the peptidyl-prolyl bond. This isomerization activity is inhibited by FK506. mFKBP60 binds Ca2+ in vitro, presumably by its C-terminal EF-hand Ca2+ binding motif, and is phosphorylated in vivo. hFKBP60 has been mapped to 7p12 and/or 7p14 by fluorescence in situ hybridization (FISH).  相似文献   
3.
4.
Squilla mantis hemocyanin is composed of two hexameric subunits but has electron microscopic profiles different from other bis-hexameric hemocyanins, e.g. Astacus and Homarus. We distinguished three different electron microscopic profiles of S. mantis hemocyanin: two sideviews and a topview. These profiles were studied using computer image alignment and correspondence analysis [Van Heel, M. and Frank, J. (1981) Ultramicroscopy 6, 187 - 194]. With the results of this analysis we were able to build a three-dimensional model for the quaternary structure of this hemocyanin. In this model the two hexamers are stacked in such a way that their hexagonal surfaces overlap to about 60% of their width. In the overlap area four subunits are arranged in two different interhexameric pairs, each forming a bridging area between the two hexamers.  相似文献   
5.
6.
7.
A patient with chronic anemia is presented who radiologically showed prominent rugae of the stomach. Angiography demonstrated an arteriovenous malformation with a large feeding artery and prominent draining veins.  相似文献   
8.
9.
10.
Conventional therapies for prostate cancer, especially in its androgen-independent form, may result in the survival of small populations of resistant cells with tumor-initiating potential. These “cancer stem cells” are believed to be responsible for cancer relapse, and therapeutic strategies targeting these cells are of great importance. Telomerase is a ribonucleoprotein enzyme responsible for telomere elongation and is activated in the majority of malignancies, including prostate cancer, but is absent in most normal cells. Putative tumor-initiating cells have significant levels of telomerase, indicating that they are an excellent target for telomerase inhibition therapy. In this review, we present some evidence for the hypothesis that conventional therapies (standard chemotherapy and/or radiation therapy) in combination with telomerase inhibitors may result in effective and more durable responses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号